Neuronetics stock prices USD 30 million public offering
Published on 11/15/2026 at 13:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSOffering expands Neuronetics financing
- Neuronetics priced 18.75 million shares at USD 1.60 each.
- Proceeds are intended partly for term-loan repayment and partly for operating needs.
- Underwriters received an option for up to 2.8125 million additional shares.
Neuronetics priced a public offering of 18,750,000 common shares at USD 1.60 per share, according to a Reuters report carried by Investing.com published on November 11. The company expected gross proceeds of about USD 30 million before underwriting discounts, commissions and other offering expenses.
Capital raise targets debt and operations
Neuronetics said part of the net proceeds would repay outstanding term-loan debt under its credit agreement with Perceptive Credit Holdings IV. The remaining funds were earmarked for sales and marketing, research and development, potential acquisitions, inventory purchases and working capital.
The underwriters received a 30-day option to buy up to 2,812,500 additional shares at the offering price, less underwriting discounts. The financing follows an amendment to Neuronetics' credit facility that reduced certain revenue covenants subject to conditions including a minimum USD 15 million prepayment.
The company said satisfying those conditions would resolve the going-concern risk referenced in recent Form 10-Q filings. William Blair acted as lead bookrunner, with BTIG and Canaccord Genuity as additional bookrunners.
Neuronetics company details
- Company: Neuronetics, Inc.
- ISIN: US64131A1051
- Ticker: STIM
- Home exchange: Nasdaq
- Offering: 18,750,000 common shares at USD 1.60 each
- Gross proceeds: Approximately USD 30 million before expenses
The Euro Stoxx 50 market overview provides broader context for European investors.
